<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Channels (Austin)</journal-id>
<journal-id journal-id-type="iso-abbrev">Channels (Austin)</journal-id>
<journal-id journal-id-type="publisher-id">KCHL</journal-id>
<journal-id journal-id-type="publisher-id">kchl20</journal-id>
<journal-title-group>
<journal-title>Channels</journal-title>
</journal-title-group>
<issn pub-type="ppub">1933-6950</issn>
<issn pub-type="epub">1933-6969</issn>
<publisher>
<publisher-name>Taylor &amp; Francis</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31070086</article-id>
<article-id pub-id-type="pmc">6527065</article-id>
<article-id pub-id-type="publisher-id">1614415</article-id>
<article-id pub-id-type="doi">10.1080/19336950.2019.1614415</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Paper</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Compound heterozygous <italic>CACNA1H</italic> mutations associated with severe congenital amyotrophy</article-title>
<alt-title alt-title-type="running-authors">M. T. CARTER ET AL.</alt-title>
<alt-title alt-title-type="running-title">CHANNELS</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7211-3731</contrib-id>
<name>
<surname>Carter</surname>
<given-names>Melissa T.</given-names>
</name>
<xref ref-type="aff" rid="AFF0001">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McMillan</surname>
<given-names>Hugh J.</given-names>
</name>
<xref ref-type="aff" rid="AFF0001">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8921-6366</contrib-id>
<name>
<surname>Tomin</surname>
<given-names>Andriy</given-names>
</name>
<xref ref-type="aff" rid="AFF0002">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0040-1109</contrib-id>
<name>
<surname>Weiss</surname>
<given-names>Norbert</given-names>
</name>
<xref ref-type="corresp" rid="AN0001"></xref>
<xref ref-type="aff" rid="AFF0002">
<sup>b</sup>
</xref>
</contrib>
<aff id="AFF0001"><label>a</label><institution>Children’s Hospital of Eastern Ontario Research Institute, University of Ottawa</institution>, Ottawa, Ontario, <country>Canada</country></aff>
<aff id="AFF0002"><label>b</label><institution>Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences</institution>, Prague, <country>Czech Republic</country></aff>
</contrib-group>
<author-notes>
<corresp id="AN0001">CONTACT Norbert Weiss <email xlink:href="weiss@uochb.cas.cz">weiss@uochb.cas.cz</email></corresp>
</author-notes>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>9</day>
<month>5</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>9</day>
<month>5</month>
<year>2019</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
<volume>13</volume>
<issue>1</issue>
<fpage seq="15">153</fpage>
<lpage>161</lpage>
<history>
<date date-type="received">
<day>24</day>
<month>4</month>
<year>2019</year>
</date>
<date date-type="rev-recd">
<day>26</day>
<month>4</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>26</day>
<month>4</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© 2019 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group.</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>The Author(s)</copyright-holder>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="kchl-13-01-1614415.pdf"></self-uri>
<abstract>
<title>ABSTRACT</title>
<p>Neuromuscular disorders encompass a wide range of conditions often associated with a genetic component. In the present study, we report a patient with severe infantile-onset amyotrophy in whom two compound heterozygous variants in the gene <italic>CACNA1H</italic> encoding for Ca<sub>v</sub>3.2 T-type calcium channels were identified. Functional analysis of Ca<sub>v</sub>3.2 variants revealed several alterations of the gating properties of the channel that were in general consistent with a loss-of-channel function. Taken together, these findings suggest that severe congenital amyoplasia may be related to <italic>CACNA1H</italic> and would represent a new phenotype associated with mutations in this gene.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>KEYWORDS</title>
<kwd>Congenital amyotrophy</kwd>
<kwd>CACNA1H</kwd>
<kwd>mutations</kwd>
<kwd>calcium channel</kwd>
<kwd>Ca<sub>v</sub>3.2 channel</kwd>
<kwd>T-type channel</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<named-content content-type="funder-name">the Institute of Organic Chemistry and Biochemistry (IOCB)</named-content>
<named-content content-type="funder-identifier">10.13039/501100010099</named-content>
</funding-source>
</award-group>
<funding-statement>A.T. is supported by a postdoctoral fellowship from the Institute of Organic Chemistry and Biochemistry (IOCB). N.W. is supported by the IOCB.</funding-statement>
</funding-group>
<counts>
<fig-count count="5"></fig-count>
<table-count count="1"></table-count>
<ref-count count="32"></ref-count>
<page-count count="9"></page-count>
</counts>
</article-meta>
</front>
<body>
<sec id="S0001" sec-type="intro">
<title>Introduction</title>
<p>Neuromuscular disorders (NMD) encompass a wide range of conditions including amyotrophic lateral sclerosis (ALS), congenital muscular dystrophies and myopathies, Duchenne muscular dystrophy, and spinal muscular atrophy. They are characterized by progressive muscle degeneration and weakness that primarily or secondarily impair skeletal muscles and their innervation. The onset of NMD ranges from <italic>in utero</italic> to old age, but primarily affect infants, children, and teenagers [<xref rid="CIT0001">1</xref>]. Although some NMD are acquired, the vast majority are genetic, and may display autosomal recessive, autosomal dominant, or X-linked inheritance [<xref rid="CIT0002">2</xref>]. It is also apparent that NMD phenotypes may vary widely even in individuals carrying the same disease-causing mutation, suggesting the existence of additional factors such as modifier genes that contribute to the onset, severity, and duration of the disease [<xref rid="CIT0003">3</xref>].</p>
<p>Recently, whole exome sequence analysis has identified two compound heterozygous recessive missense mutations in the gene <italic>CACNA1H</italic> in a patient with ALS [<xref rid="CIT0004">4</xref>,<xref rid="CIT0005">5</xref>]. <italic>CACNA1H</italic> encodes for Ca<sub>v</sub>3.2 channel, a member of the voltage-gated calcium channel family [<xref rid="CIT0006">6</xref>]. Ca<sub>v</sub>3.2 channels are widely expressed throughout the body including the central and peripheral nervous system, heart, kidney, smooth muscle, as well as in several neuroendocrine organs [<xref rid="CIT0007">7</xref>]. Through their ability to support low-threshold calcium influx (T-type current), they serve essential physiological processes including neuronal firing, hormone secretion, smooth muscle contraction, and myoblast fusion [<xref rid="CIT0008">8</xref>]. Their physiological implication is further exemplified by the existence of polymorphisms in <italic>CACNA1H</italic> associated with a number of human disorders including several forms of epilepsy [<xref rid="CIT0009">9</xref>], autism spectrum disorders [<xref rid="CIT0010">10</xref>,<xref rid="CIT0011">11</xref>], congenital pain [<xref rid="CIT0012">12</xref>], primary aldosteronism [<xref rid="CIT0013">13</xref>,<xref rid="CIT0014">14</xref>], and ALS [<xref rid="CIT0004">4</xref>,<xref rid="CIT0005">5</xref>].</p>
<p>In the present study, we report a patient with severe congenital amyotrophy in whom two compound heterozygous variants in <italic>CACNA1H</italic> were identified. Functional analysis of Ca<sub>v</sub>3.2 variants revealed altered channel gating, strengthening the genetic association of <italic>CACNA1H</italic> with NMD.</p>
</sec>
<sec id="S0002">
<title>Materials and methods</title>
<sec id="S0002-S2001">
<title>Whole exome sequencing</title>
<p>Whole exome sequencing was performed at a commercial laboratory (GeneDx). Using genomic DNA from the proband and both parents, exonic regions and flanking splice junctions were selected, sequenced, and analyzed as per established proprietary protocols using an Illumina sequencing system with 100 bp or greater paired end reads. Reads were aligned to human genome build GRCh37/UCSC hg19 and analyzed for sequence variants using a custom‐developed analysis tool (Xome Analyzer). Mean depth of coverage was 100x.</p>
</sec>
<sec id="S0002-S2002">
<title>Plasmid cDNA constructs</title>
<p>The human wild-type Ca<sub>v</sub>3.2 in pcDNA3.1 [<xref rid="CIT0015">15</xref>] was used as template to introduce separately the V681L and D1233H mutations by site-directed mutagenesis using the Q5® Site-Directed Mutagenesis Kit (NEB) and the following pairs of primers: p.V681L: 5‘-GGGCCTCAGTttgCCCTGCCC-3‘ (forward) and 5‘-GACAGATGGCCAGGGGCC-3‘ (reverse); p.D1233H: 5‘-CCTGCGCATCcacAGCCACCG-3‘ (forward) and 5‘-AAGAAGTCGCTGGGCAGG-3‘ (reverse). Final constructs were verified by sequencing.</p>
</sec>
<sec id="S0002-S2003">
<title>Cell culture and heterologous expression</title>
<p>Human embryonic kidney tsA-201 cells were grown in DMEM medium supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin (all media purchased from Invitrogen) and maintained under standard conditions at 37°C in a humidified atmosphere containing 5% CO<sub>2</sub>. Heterologous expression of Ca<sub>v</sub>3.2 channels was performed by transfecting cells with plasmid cDNAs encoding for Ca<sub>v</sub>3.2 channel variants using the calcium/phosphate method as previously described [<xref rid="CIT0016">16</xref>].</p>
</sec>
</sec>
<sec id="S0003">
<title>Recording of T-type currents</title>
<p>Patch clamp recording of T-type currents in tsA-201 cells expressing Ca<sub>v</sub>3.2 channels was performed 72 h after transfection in the whole-cell configuration at room temperature (22–24°C). The bath solution contained (in millimolar): 5 BaCl2, 5 KCl, 1 MgCl2, 128 NaCl, 10 TEA-Cl, 10 D-glucose, 10 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (pH 7.2 with NaOH). Patch pipettes were filled with a solution containing (in millimolar): 110 CsCl, 3 Mg-ATP, 0.5 Na-GTP, 2.5 gCl2, 5 D-glucose, 10 EGTA, and 10 HEPES (pH 7.4 with CsOH), and had a resistance of 2–4 MΩ. Recordings were performed using an Axopatch 200B amplifier (Axon Instruments) and acquisition and analysis were performed using pClamp 10 and Clampfit 10software, respectively (Axon Instruments). The linear leak component of the current was corrected online, and current traces were digitized at 10 kHz and filtered at 2 kHz. The voltage dependence of activation of Ca<sub>v</sub>3.2 channels was determined by measuring the peak T-type current amplitude in response to 150 ms depolarizing steps to various potentials applied every 10 s from a holding membrane potential of −100 mV. The current-voltage relationship (I/V) curve was fitted with the following modified Boltzmann <xref rid="M0001">Equation (1)</xref>:
<disp-formula-group id="M0001"><disp-formula><label>(1)</label><alternatives><graphic orientation="portrait" position="float" xlink:href="kchl-13-01-1614415-em0001.jpg"></graphic><mml:math id="d27e348"><mml:mi>I</mml:mi><mml:mfenced close=")" open="("><mml:mi>V</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mi>G</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi><mml:mrow><mml:mfrac><mml:mrow><mml:mfenced close=")" open="("><mml:mrow><mml:mi>V</mml:mi><mml:mo>−</mml:mo><mml:mi>V</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">v</mml:mi></mml:mrow></mml:mrow></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mrow><mml:mrow><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">x</mml:mi><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:mfenced close=")" open="("><mml:mrow><mml:mi>V</mml:mi><mml:mn>0.5</mml:mn><mml:mo>−</mml:mo><mml:mi>V</mml:mi></mml:mrow></mml:mfenced></mml:mrow><mml:mi>k</mml:mi></mml:mfrac></mml:mrow></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula></disp-formula-group></p>
<p>with <italic>I</italic>(<italic>V</italic>) being the peak current amplitude at the command potential <italic>V, G</italic>max the maximum conductance, <italic>V</italic>rev the reversal potential, <italic>V</italic><sub>0.5</sub> the half-activation potential, and <italic>k</italic> the slope factor. The voltage dependence of the whole-cell Ba<sup>2+</sup> conductance was calculated using the following modified Boltzmann <xref rid="M0002">Equation (2)</xref>:
<disp-formula-group id="M0002"><disp-formula><label>(2)</label><alternatives><graphic orientation="portrait" position="float" xlink:href="kchl-13-01-1614415-em0002.jpg"></graphic><mml:math id="d27e448"><mml:mi>G</mml:mi><mml:mfenced close=")" open="("><mml:mi>V</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mi>G</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mrow><mml:mrow><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">x</mml:mi><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mi>V</mml:mi><mml:mn>0.5</mml:mn><mml:mo>−</mml:mo><mml:mi>V</mml:mi></mml:mrow></mml:mfenced></mml:mrow><mml:mi>k</mml:mi></mml:mfrac></mml:mrow></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula></disp-formula-group></p>
<p>with <italic>G</italic>(<italic>V</italic>) being the Ba<sup>2+</sup> conductance at the command potential <italic>V</italic>.</p>
<p>The voltage dependence of the steady-state inactivation of Ca<sub>v</sub>3.2 channels was determined by measuring the peak T-type current amplitude in response to a 150 ms depolarizing step to −20 mV applied after a 5 s-long conditioning prepulse ranging from −120 mV to −30 mV. The current amplitude obtained during each test pulse was normalized to the maximal current amplitude and plotted as a function of the prepulse potential. The voltage dependence of the steady-state inactivation was fitted with the following two-state Boltzmann function (3):
<disp-formula-group id="M0003"><disp-formula><label>(3)</label><alternatives><graphic orientation="portrait" position="float" xlink:href="kchl-13-01-1614415-em0003.jpg"></graphic><mml:math id="d27e524"><mml:mi>I</mml:mi><mml:mfenced close=")" open="("><mml:mi>V</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mi>I</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mrow><mml:mrow><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">x</mml:mi><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:mfenced close=")" open="("><mml:mrow><mml:mi>V</mml:mi><mml:mo>−</mml:mo><mml:mi>V</mml:mi><mml:mn>0.5</mml:mn></mml:mrow></mml:mfenced></mml:mrow><mml:mi>k</mml:mi></mml:mfrac></mml:mrow></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula></disp-formula-group></p>
<p>with <italic>I</italic><sub>max</sub> corresponding to the maximal peak current amplitude and <italic>V</italic><sub>0.5</sub> to the half-inactivation voltage.</p>
<p>The recovery from inactivation was assessed using a double-pulse protocol from a holding potential of −100 mV. The cell membrane was depolarized for 2 s at 0 mV (inactivating prepulse) to ensure complete inactivation of the channel, and then to −20 mV for 150 ms (test pulse) after an increasing time period (interpulse) ranging between 0.1 ms and 2 s at −100 mV. The peak current from the test pulse was plotted as a ratio of the maximum prepulse current versus interpulse interval. The data were fitted with the following single-exponential function (4):
<disp-formula-group id="M0004"><disp-formula><label>(4)</label><alternatives><graphic orientation="portrait" position="float" xlink:href="kchl-13-01-1614415-em0004.jpg"></graphic><mml:math id="d27e593"><mml:mrow><mml:mfrac><mml:mi>I</mml:mi><mml:mrow><mml:mi>I</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:mfrac></mml:mrow><mml:mo>=</mml:mo><mml:mi>A</mml:mi><mml:mo>×</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>e</mml:mi><mml:mi>x</mml:mi><mml:mi>p</mml:mi><mml:mrow><mml:mfrac><mml:mrow><mml:mo>−</mml:mo><mml:mi>t</mml:mi></mml:mrow><mml:mi>τ</mml:mi></mml:mfrac></mml:mrow></mml:mrow></mml:mfenced></mml:math></alternatives></disp-formula></disp-formula-group></p>
<p>where τ the time constant of channel recovery from inactivation.</p>
<sec id="S0003-S2001">
<title>Statistical analysis</title>
<p>Values are presented as mean ± S.E.M. for <italic>n</italic> experiments. Statistical significance was determined using a one-way ANOVA test followed by Dunnett multiple comparison test. * <italic>p</italic>&lt; 0.05, ** <italic>p</italic>&lt; 0.005, *** <italic>p</italic>&lt; 0.001.</p>
</sec>
</sec>
<sec id="S0004">
<title>Results</title>
<sec id="S0004-S2001">
<title>Clinical characteristics and genetic analysis</title>
<p>The patient is a 13-month-old girl who was born at term following a pregnancy complicated by severe polyhydramnios treated with amnioreduction at 31 weeks. Her birth weight was 2.9 kg (20%ile). Her Apgar score (Appearance, Pulse, Grimace, Activity, and Respiration) used to summarize the health of newborn children was critically low (2 at 1-min and 5-min) and was intubated for poor respiratory effort, absent gag and suck. She had arthrogryposis, areflexia, and no antigravity movements. Nerve conduction studies showed intact sensory but absent motor responses. Magnetic resonance imaging (MRI) of her brain was unremarkable. However, the MRI of her muscles noted severe and diffuse amyoplasia with largest muscles being right biceps femoris (8 x 5 mm at widest diameter) and medial gastrocnemius (8 x 3 mm) (<xref rid="F0001">Figure 1(a,b)</xref>). A biopsy of the vastus lateralis revealed no viable muscle and repeat biopsies of the gastrocnemius noted a strong predominance of type 1 fibers and a marked variability of fiber size. She remains fully ventilated via tracheostomy with no antigravity movement at 13 months old. Whole exome sequencing identified two compound heterozygous variants (c.2041G&gt;T and c.3697G&gt;C) in <italic>CACNA1H</italic>, causing the substitution of the valine (V) 681 by a leucine (L) (p.V681L) and of the aspartic acid (D) 1233 by a histidine (H) (p.D1233H) in the Ca<sub>v</sub>3.2 T-type calcium channel, respectively. These mutations were inherited from the father and mother, respectively, who have no symptoms of muscle disease (<xref rid="F0001">Figure 1(c</xref>)). The p.V681L and p.D1233H mutations are located within the intracellular loops connecting domains I-II and domains II-III of Ca<sub>v</sub>3.2 channel, respectively (<xref rid="F0001">Figure 1(d</xref>)).<fig fig-type="figure" id="F0001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1080/19336950.2019.1614415-F0001</object-id><label>Figure 1.</label><caption><p>Whole exome sequencing identifies two <italic>CACNA1H</italic> missense mutations associated with severe congenital amyotrophy. (a) Whole-body magnetic resonance T1 weighted images (T1W1) 3T (axial view) of the thigh at 6 weeks old revealed severe muscle amyotrophy. No muscle was visualized in the anterior compartment. Her right biceps femoris (arrow) measured 8 × 5 mm at its widest. (b) For comparison, a T1WI (axial view) from a hypotonic boy with nemaline myopathy was performed at 4 months old. His biceps femoris measured 14 × 9 mm. <italic>F</italic>: femur. (c) Family pedigree chart. Filled and open symbols indicate affected and unaffected individuals, respectively. (d) Location of the p.V681L (blue circle) and p.D1233H mutations (orange circle) within the secondary membrane topology of Ca<sub>v</sub>3.2 channel.</p></caption><graphic content-type="color" specific-use="web-only" xlink:href="kchl-13-01-1614415-g001"></graphic></fig></p>
</sec>
<sec id="S0004-S2002">
<title>Expression of Ca<sub>v</sub>3.2 channel variants</title>
<p>To assess the functional consequence of <italic>CACNA1H</italic> variants, the two mutations were introduced separately into the human Ca<sub>v</sub>3.2 channel, and functional expression was assessed by patch clamp recording of T-type currents in tsA-201 cells expressing Ca<sub>v</sub>3.2 channel variants. Cells expressing WT, V681L and D1233H Ca<sub>v</sub>3.2 channel variants, or co-expressing the two-channel variants (V681L + D1233H) to resemble the heterozygous status of the patient for the two mutations, displayed characteristic low-threshold voltage-activated T-type currents (<xref rid="F0002">Figure 2(a,b)</xref>). The maximal T-type conductance in cells expressing Ca<sub>v</sub>3.2 variants was similar (V681L: 756 ± 49 pS/pF, <italic>n</italic> = 45; D1233H: 640 ± 60 pS/pF, <italic>n</italic> = 48) and was not significantly different from cells expressing the WT channel (688 ± 59, <italic>n</italic> = 45) (<xref rid="F0002">Figure 2(c,d)</xref>) and <xref rid="T0001">Table (1</xref>)).<table-wrap id="T0001" orientation="landscape" position="float"><object-id pub-id-type="doi">10.1080/19336950.2019.1614415-T0001</object-id><label>Table 1.</label><caption><p>Electrophysiological properties of human Ca<sub>v</sub>3.2 channel variants expressed in tsA-201 cells. Activation and inactivation kinetic values are shown for a depolarization step to −40 mV from a holding potential of −100 mV.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col align="left" width="1*"/><col align="left" width="1*"/><col align="char" char="±" width="1*"/><col align="char" char="." width="1*"/><col align="char" char="±" width="1*"/><col align="char" char="." width="1*"/><col align="char" char="±" width="1*"/><col align="char" char="." width="1*"/><col align="left" width="1*"/><col align="char" char="±" width="1*"/><col align="char" char="." width="1*"/><col align="char" char="±" width="1*"/><col align="char" char="." width="1*"/><col align="char" char="±" width="1*"/><col align="char" char="." width="1*"/></colgroup><thead><tr><th align="left"> </th><th align="center" colspan="7">Activation<hr/></th><th align="center" colspan="5">Inactivation<hr/></th><th align="center" char="±" colspan="2">RFI<hr/></th></tr><tr><th align="left">Ca<sub>v</sub>3.2 variant</th><th align="center">V<sub>0.5</sub> (mV)</th><th align="center" char="±"><italic>k</italic></th><th align="center" char=".">(n)</th><th align="center" char="±">τ (ms)</th><th align="center" char=".">(n)</th><th align="center" char="±"><italic>G</italic><sub>max</sub> (pS/pF)</th><th align="center" char=".">(n)</th><th align="center">V<sub>0.5</sub> (mV)</th><th align="center" char="±"><italic>k</italic></th><th align="center" char=".">(n)</th><th align="center" char="±">τ (ms)</th><th align="center" char=".">(n)</th><th align="center" char="±">τ (ms)</th><th align="center" char=".">(n)</th></tr></thead><tbody><tr><td align="left">WT</td><td align="left">−39.9 ± 0.6</td><td align="char" char="±">5.6 ± 0.2</td><td align="char" char=".">45</td><td align="char" char="±">5.8 ± 0.2</td><td align="char" char=".">45</td><td align="char" char="±">688 ± 59</td><td align="char" char=".">45</td><td align="left">−69.8 ± 0.6</td><td align="char" char="±">4.4 ± 0.1</td><td align="char" char=".">32</td><td align="char" char="±">21.9 ± 1.0</td><td align="char" char=".">32</td><td align="char" char="±">377 ± 35</td><td align="char" char=".">11</td></tr><tr><td align="left">V681L</td><td align="left">−43.4 ± 0.9**</td><td align="char" char="±">5.4 ± 0.2</td><td align="char" char=".">45</td><td align="char" char="±">5.1 ± 0.3</td><td align="char" char=".">45</td><td align="char" char="±">756 ± 49</td><td align="char" char=".">45</td><td align="left">−75.3 ± 1.2***</td><td align="char" char="±">4.4 ± 0.1</td><td align="char" char=".">30</td><td align="char" char="±">18.4 ± 0.9*</td><td align="char" char=".">30</td><td align="char" char="±">373 ± 29</td><td align="char" char=".">18</td></tr><tr><td align="left">D1233H</td><td align="left">−41.1 ± 0.8</td><td align="char" char="±">5.0 ± 0.2*</td><td align="char" char=".">48</td><td align="center" char="±">5.8 + 0.3</td><td align="char" char=".">48</td><td align="char" char="±">640 ± 60</td><td align="char" char=".">48</td><td align="left">−70.0 ± 0.7</td><td align="char" char="±">4.1 ± 0.1</td><td align="char" char=".">34</td><td align="char" char="±">19.3 ± 1.1</td><td align="char" char=".">34</td><td align="char" char="±">343 ± 30</td><td align="char" char=".">15</td></tr><tr><td align="left">V681L+D1233H</td><td align="left">−40.8 ± 0.6</td><td align="char" char="±">5.6 ± 0.1</td><td align="char" char=".">30</td><td align="char" char="±">5.7 ± 0.2</td><td align="char" char=".">30</td><td align="char" char="±">644 ± 58</td><td align="char" char=".">30</td><td align="left">−74.0 ± 1.0**</td><td align="char" char="±">4.7 ± 0.2</td><td align="char" char=".">31</td><td align="char" char="±">20.6 ± 0.8</td><td align="char" char=".">31</td><td align="char" char="±">435 ± 24</td><td align="char" char=".">27</td></tr></tbody></table></table-wrap>
<fig fig-type="figure" id="F0002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1080/19336950.2019.1614415-F0002</object-id><label>Figure 2.</label><caption><p>Functional expression of Ca<sub>v</sub>3.2 variants. (a) Representative T-type current traces recorded from cells expressing WT (black traces), V681L (blue traces), D1233H (orange traces), and co-expressing V681L and D1233H channel variants (purple traces) in response to 150 ms depolarizing steps ranging between −90 mV and 30 mV from a holding potential of −100 mV. (b) Corresponding mean peak current-voltage (<italic>I</italic>/<italic>V</italic>) relationship. (c) Corresponding mean maximal macroscopic conductance (<italic>G</italic><sub>max</sub>) values obtained from the fit of the <italic>I</italic>/<italic>V</italic> curves with the modified Boltzmann <xref rid="M0001">Equation (1)</xref>. (d) Cumulative frequency plot of data shown in (C). Dotted lines indicate the median values for each distribution (WT: 558 pS/pF; V681L: 648 pS/pF; D1233H: 601 pS/pF; V681L + D1233H: 615 pS/pF).</p></caption><graphic content-type="color" specific-use="web-only" xlink:href="kchl-13-01-1614415-g002"></graphic></fig></p>
<p>These results indicate that the V681L and D1233H mutations do not alter the expression level of Ca<sub>v</sub>3.2 channels.</p>
</sec>
<sec id="S0004-S2003">
<title>Gating properties of Ca<sub>v</sub>3.2 channel variants</title>
<p>To assess the functional properties of Ca<sub>v</sub>3.2 variants, we analyzed the voltage-dependence of T-type current activation in cells expressing WT, V681L, D1233H, or co-expressing the V681L and D1233H channel variants (co-expression of the two separate cDNA constructs each carrying one mutation). The mean half-activation potential in cells expressing the V681L variant was shifted by 3.5 mV (<italic>p</italic> = 0.0039) toward hyperpolarized potentials (−43.4 ± 0.9 mV, <italic>n</italic> = 45) compared to cells expressing the WT channel (−39.9 ± 0.6 mV, <italic>n</italic> = 45) (<xref rid="F0003">Figure 3(a,b)</xref> and <xref rid="T0001">Table (1</xref>)). Although the mean half-activation potential of T-type currents measured in cells expressing the D1233H variant was not significantly altered, we observed a significant decrease (<italic>p</italic> = 0.0429) of the inactivation slope factor (5.0 ± 0.2, <italic>n</italic> = 48) compared to WT channels (5.6 ± 0.2, <italic>n</italic> = 45) (<xref rid="F0003">Figure 3(c</xref>) and <xref rid="T0001">Table (1</xref>)). To further investigate the gating properties of Ca<sub>v</sub>3.2 variants, we assessed the voltage-dependence of the steady-state inactivation of the T-type current. We observed a hyperpolarized shift of the mean half-inactivation potential by 5.5 mV (<italic>p</italic> &lt; 0.0001) in cells expressing the V681L variant alone (−75.3 ± 1.2 mV, <italic>n</italic> = 30) and by 4.2 mV (<italic>p</italic> = 0.0027) in cells co-expressing the V681L and D1233H variants (−74.0 ± 1.0 mV, <italic>n</italic> = 31) compared to cells expressing the WT channel (−69.8 ± 0.6 mV, <italic>n</italic> = 32) (<xref rid="F0003">Figure 3(d–f)</xref> and <xref rid="T0001">Table (1</xref>)). In contrast, the voltage-dependence of steady-state inactivation of the T-type current in cells expressing the D1233H remained unaltered (<xref rid="F0003">Figure 3(d–f)</xref> and <xref rid="T0001">Table (1</xref>)). In addition, recovery from inactivation (<xref rid="F0003">Figure 3(g,h)</xref> and <xref rid="T0001">Table (1</xref>)) as well as inactivation and inactivation kinetics remain similar between the channel variants, and only a mild acceleration of the inactivation kinetic of the V681L variant (18.4 ± 0.9, <italic>n</italic> = 30) was observed compared to the WT channel (21.9 ± 1.0, n = 45) (<xref rid="F0003">Figure 3(i</xref>) and <xref rid="T0001">Table (1</xref>)).<fig fig-type="figure" id="F0003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1080/19336950.2019.1614415-F0003</object-id><label>Figure 3.</label><caption><p>Electrophysiological properties of Ca<sub>v</sub>3.2 variants. (a) Mean normalized voltage-dependence of T-type current activation for cells expressing WT (white circles), V681L (blue circles), D1233H (orange circles), and co-expressing V681L and D1233H channel variants (purple circles). (b) Corresponding mean half-activation potential values obtained from the fit of the activation curves with the modified Boltzmann <xref rid="M0002">Equation (2)</xref>. (c) Corresponding mean activation slope factor. (d) Mean normalized voltage-dependence of steady-state inactivation. (e) Corresponding mean half-inactivation potential values obtained from the fit of the inactivation curves with the two-state Boltzmann function (3). (f) Corresponding mean inactivation slope factor. (g) Mean normalized recovery from inactivation kinetics. (h) Corresponding mean time constant τ values of recovery from inactivation obtained by fitting recovery curves with the single-exponential function (4). (i) Mean time constant τ values of activation and inactivation of T-type currents obtained by fitting the rising and decay phase of the current with a single exponential function, respectively.</p></caption><graphic content-type="color" specific-use="web-only" xlink:href="kchl-13-01-1614415-g003"></graphic></fig></p>
<p>Collectively, these data indicate that the V681L and D1233H mutations produce mild but significant alterations of the gating of Ca<sub>v</sub>3.2 by altering the voltage dependence of activation and inactivation of the channel.</p>
</sec>
<sec id="S0004-S2004">
<title>Window current of Ca<sub>v</sub>3.2 channel variants</title>
<p>Considering the effect of the V681L and D1233H mutations on the voltage dependence of activation and inactivation of Ca<sub>v</sub>3.2 channels, we analyzed the window current of Ca<sub>v</sub>3.2 variants as the area under the overlap between the activation and inactivation curves (<xref rid="F0004">Figure 4(a</xref>)). We observed a decrease of the window current generated by Ca<sub>v</sub>3.2 variants. For instance, the mean area of the window current was decreased by 22% (<italic>p</italic> = 0.0055) and 19% (<italic>p</italic> = 0.0188) in cells expressing the V681L and D1233H variants, respectively (<xref rid="F0004">Figure 4(b,c)</xref>). Consistent with this observation, the window current in cells co-expressing the V681L and D1233H channel variants were decreased by 22% (<italic>p</italic> = 0.0079) compared to cells expressing the WT channel (<xref rid="F0004">Figure 4(b,c)</xref>). In addition, we observed a hyperpolarized shift of the peak-voltage of the window current by 4.6 mV (<italic>p</italic> &lt; 0.0001) in cells expressing the V681L variant (<xref rid="F0004">Figure 4(d</xref>)).<fig fig-type="figure" id="F0004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1080/19336950.2019.1614415-F0004</object-id><label>Figure 4.</label><caption><p>Window current of Ca<sub>v</sub>3.2 variants. (a) Representative activation (<italic>G</italic>/<italic>G</italic><sub>max</sub>) – inactivation curves (<italic>I</italic>/<italic>I</italic><sub>max</sub>) showing the window current for cells expressing WT (black), V681L (blue), D1233H (orange), and co-expressing V681L and D1233H channel variants (purple). (b) Corresponding mean window current measured as the area of the overlap between the activation and inactivation curves. (c) Corresponding frequency plot for each distribution. The dotted lines indicate the median values (WT: 0.4936; V681L: 0.4047; D1233H: 0.3792; V681L + D1233H: 0.4233). (D) Corresponding mean peak-voltage of the window currents. (d) Corresponding mean peak-voltage of the window currents.</p></caption><graphic content-type="color" specific-use="web-only" xlink:href="kchl-13-01-1614415-g004"></graphic></fig></p>
<p>Altogether, these data indicate that alteration of the voltage-dependence of activation and inactivation caused by the V681L and D1233H mutations ultimately translates into a decrease of the window current supported by Ca<sub>v</sub>3.2 variants.</p>
</sec>
</sec>
<sec id="S0005">
<title>Discussion</title>
<p>Here we describe two compounds heterozygous <italic>CACNA1H</italic> mutations identified in a case-unaffected-parents trio with infantile-onset NMD. The two mutations, V681L and D1233H, are located within the intracellular loops connecting domains I and II (I-II loop) and II and III (II-III loop) of the Ca<sub>v</sub>3.2 T-type calcium channel. Previous structure-function studies have documented the role of the I-II loop of Ca<sub>v</sub>3.2 in the control of the gating and surface expression of the channel [<xref rid="CIT0017">17</xref>,<xref rid="CIT0018">18</xref>]. Additionally, several human mutations associated with idiopathic generalized epilepsy and located within the I-II loop and II-III-loop of Ca<sub>v</sub>3.2 alter channel gating [<xref rid="CIT0019">19</xref>–<xref rid="CIT0022">22</xref>]. Consistent with these observations, our functional analysis of Ca<sub>v</sub>3.2 missense variants revealed several alterations of the gating properties of the channel. For instance, the V681L mutation produced a hyperpolarized shift of the voltage dependence of activation, as well as a concomitant hyperpolarized shift of the voltage dependence of inactivation. From a mechanistic viewpoint, this apparent mix gain- and loss-of-channel function can be explained by a model in which the V681L mutation may destabilize the closed state of the channel. This notion has recently been proposed for Ca<sub>v</sub>3.3 channels [<xref rid="CIT0023">23</xref>] and is consistent with the observation that T-type channels inactivate from both open and closed states [<xref rid="CIT0024">24</xref>,<xref rid="CIT0025">25</xref>]. Of particular importance is the observation that as a result of the effect on the voltage-dependence of activation and inactivation, the V681L mutation caused a marked decrease of the window current supported by Ca<sub>v</sub>3.2 channel. Likewise, decrease of the window current was also observed with the D1233H as a result of the increased slope of the activation curve without alteration of the mid-voltage.</p>
<p>The question then arises as to how channel defects caused by the V681L and D1233H mutations may contribute to the disease phenotype. Alteration of the window current appears particularly relevant as an underlying mechanism of the amyotrophy observed in the proband for several reasons. First, Ca<sub>v</sub>3.2 channels are functionally expressed in embryonic skeletal muscle fibers where they present a developmental expression pattern consistent with a role in early-stage muscle differentiation. For instance, the T-type current density in muscle fibers increases transiently during prenatal myogenesis to reach a maximum expression at embryonic day E16 before to decrease dramatically until birth [<xref rid="CIT0026">26</xref>]. Second, extracellular calcium is required for the fusion of myoblasts [<xref rid="CIT0027">27</xref>] and a rise in intracellular calcium level precedes fusion [<xref rid="CIT0028">28</xref>,<xref rid="CIT0029">29</xref>]. Third, it was proposed that rise in intracellular calcium levels occurs via the window current supported by Ca<sub>v</sub>3.2 channels in response to the hyperpolarization of the plasma membrane that proceeds the fusion of the myoblasts [<xref rid="CIT0030">30</xref>]. Therefore, our observation that the p.V681L and p.D1233H mutations caused a reduction of the window current could have an important consequence at early stages of muscle differentiation and may represent an underlying mechanism of infantile-onset amyotrophy (<xref rid="F0005">Figure 5(a</xref>)). Additionally, several studies have reported the expression of T-type channels in motor neurons [<xref rid="CIT0031">31</xref>,<xref rid="CIT0032">32</xref>]. Although the role of T-type channels in motor neurons has not been investigated yet, it is likely that they contribute to some forms of neuronal excitability. Therefore, alteration of T-type channel activity is likely to affect muscle afferent signaling which may participate to some extend to motor symptoms.<fig fig-type="figure" id="F0005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1080/19336950.2019.1614415-F0005</object-id><label>Figure 5.</label><caption><p>Hypothetical model for altered myogenesis by Ca<sub>v</sub>3.2 variants. While the membrane potential of undifferentiated myoblast is about −8 mV, sequential expression of the slow-inactivating voltage-gated ether-a-go-go (EAG) and inward-rectifying Kir2.1 potassium channels brings the membrane potential to approximately −65 mV (red line), allowing window calcium influx through Ca<sub>v</sub>3.2 channels (grey line) required for the fusion of myoblasts. Reduced window current caused the by V681L and D1233H mutations results in a decreased window calcium influx (purple line) which potentially compromises early stage myogenesis. Adapted from [<xref rid="CIT0030">30</xref>].</p></caption><graphic content-type="color" specific-use="web-only" xlink:href="kchl-13-01-1614415-g005"></graphic></fig></p>
<p>In summary, we identified new <italic>CACNA1H</italic> variants in an individual with infantile-onset NMD. Clinical, histopathological, and electrophysiological findings indicating a loss-of-Ca<sub>v</sub>3.2 channel function suggest that severe congenital amyoplasia may be related to <italic>CACNA1H</italic>, which add to the growing list of <italic>CACNA1H</italic> channelopathies and would represent a new phenotype associated with mutations in this gene.</p>
</sec>
</body>
<back>
<sec>
<title>Acknowledgments</title>
<p>We thank family members for participating in this study.</p>
</sec>
<sec id="S0006">
<title>Disclosure statement</title>
<p>The authors report no conflict of interest.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="CIT0001">
<label>[1]</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zatz</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Passos-Bueno</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Vainzof</surname><given-names>M.</given-names></name></person-group>
<article-title>Neuromuscular disorders: genes, genetic counseling and therapeutic trials</article-title>. <source/>Genet Mol Biol. <year>2016</year>;<volume>39</volume>(<issue>3</issue>):<fpage>339</fpage>–<lpage>348</lpage>.<pub-id pub-id-type="pmid">27575431</pub-id></mixed-citation>
</ref>
<ref id="CIT0002">
<label>[2]</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Laing</surname><given-names>NG.</given-names></name></person-group>
<article-title>Genetics of neuromuscular disorders</article-title>. <source/>Crit Rev Clin Lab Sci. <year>2012</year>;<volume>49</volume>(<issue>2</issue>):<fpage>33</fpage>–<lpage>48</lpage>.<pub-id pub-id-type="pmid">22468856</pub-id></mixed-citation>
</ref>
<ref id="CIT0003">
<label>[3]</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lamar</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>McNally</surname><given-names>EM</given-names></name></person-group>
<article-title>Genetic modifiers for neuromuscular diseases</article-title>. <source/>J Neuromuscul Dis. <year>2014</year>;<volume>1</volume>(<issue>1</issue>):<fpage>3</fpage>–<lpage>13</lpage>.<pub-id pub-id-type="pmid">25729645</pub-id></mixed-citation>
</ref>
<ref id="CIT0004">
<label>[4]</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Steinberg</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Koboldt</surname><given-names>DC</given-names></name>, et al</person-group>
<article-title>Exome sequencing of case-unaffected-parents trios reveals recessive and de novo genetic variants in sporadic ALS</article-title>. <source/>Sci Rep. <year>2015</year>;<volume>5</volume>:<fpage>9124</fpage>.<pub-id pub-id-type="pmid">25773295</pub-id></mixed-citation>
</ref>
<ref id="CIT0005">
<label>[5]</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rzhepetskyy</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Lazniewska</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Blesneac</surname><given-names>I</given-names></name>, et al</person-group>
<article-title>CACNA1H missense mutations associated with amyotrophic lateral sclerosis alter Cav3.2 T-type calcium channel activity and reticular thalamic neuron firing</article-title>. <source/>Channels (Austin). <year>2016</year>;<fpage>466</fpage>–<lpage>477</lpage>.<pub-id pub-id-type="pmid">27331657</pub-id></mixed-citation>
</ref>
<ref id="CIT0006">
<label>[6]</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weiss</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Zamponi</surname><given-names>GW</given-names></name></person-group>
<article-title>T-type calcium channels: from molecule to therapeutic opportunities</article-title>. <source/>Int J Biochem Cell Biol. <year>2019</year>;<volume>108</volume>:<fpage>34</fpage>–<lpage>39</lpage>.<pub-id pub-id-type="pmid">30648620</pub-id></mixed-citation>
</ref>
<ref id="CIT0007">
<label>[7]</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perez-Reyes</surname><given-names>E</given-names></name></person-group>
<article-title>Molecular physiology of low-voltage-activated t-type calcium channels</article-title>. <source/>Physiol Rev. <year>2003</year>;<volume>83</volume>(<issue>1</issue>):<fpage>117</fpage>–<lpage>161</lpage>.<pub-id pub-id-type="pmid">12506128</pub-id></mixed-citation>
</ref>
<ref id="CIT0008">
<label>[8]</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zamponi</surname><given-names>GW</given-names></name>, <name name-style="western"><surname>Striessnig</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Koschak</surname><given-names>A</given-names></name>, et al</person-group>
<article-title>The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential</article-title>. <source/>Pharmacol Rev. <year>2015</year>;<volume>67</volume>(<issue>4</issue>):<fpage>821</fpage>–<lpage>870</lpage>.<pub-id pub-id-type="pmid">26362469</pub-id></mixed-citation>
</ref>
<ref id="CIT0009">
<label>[9]</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gambardella</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Labate</surname><given-names>A</given-names></name></person-group>
<article-title>The role of calcium channel mutations in human epilepsy</article-title>. <source/>Prog Brain Res. <year>2014</year>;<volume>213</volume>:<fpage>87</fpage>–<lpage>96</lpage>.<pub-id pub-id-type="pmid">25194484</pub-id></mixed-citation>
</ref>
<ref id="CIT0010">
<label>[10]</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Splawski</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Yoo</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>Stotz</surname><given-names>SC</given-names></name>, et al</person-group>
<article-title>CACNA1H mutations in autism spectrum disorders</article-title>. <source/>J Biol Chem. <year>2006</year>;<volume>281</volume>(<issue>31</issue>):<fpage>22085</fpage>–<lpage>22091</lpage>.<pub-id pub-id-type="pmid">16754686</pub-id></mixed-citation>
</ref>
<ref id="CIT0011">
<label>[11]</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>AT</given-names></name>, <name name-style="western"><surname>Dai</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Martinez-Agosto</surname><given-names>JA</given-names></name>, et al</person-group>
<article-title>Support for calcium channel gene defects in autism spectrum disorders</article-title>. <source/>Mol Autism. <year>2012</year>;<volume>3</volume>(<issue>1</issue>):<fpage>18</fpage>.<pub-id pub-id-type="pmid">23241247</pub-id></mixed-citation>
</ref>
<ref id="CIT0012">
<label>[12]</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Souza</surname><given-names>IA</given-names></name>, <name name-style="western"><surname>Gandini</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Wan</surname><given-names>MM</given-names></name>, et al</person-group>
<article-title>Two heterozygous Cav3.2 channel mutations in a pediatric chronic pain patient: recording condition-dependent biophysical effects</article-title>. <source/>Pflugers Arch. <year>2016</year>;<volume>468</volume>(<issue>4</issue>):<fpage>635</fpage>–<lpage>642</lpage>.<pub-id pub-id-type="pmid">26706850</pub-id></mixed-citation>
</ref>
<ref id="CIT0013">
<label>[13]</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scholl</surname><given-names>UI</given-names></name>, <name name-style="western"><surname>Stölting</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Nelson-Williams</surname><given-names>C</given-names></name>, et al</person-group>
<article-title>Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism</article-title>. <source/>Elife. <year>2015</year>;<volume>4</volume>:<fpage>e06315</fpage>.<pub-id pub-id-type="pmid">25907736</pub-id></mixed-citation>
</ref>
<ref id="CIT0014">
<label>[14]</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Daniil</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Fernandes-Rosa</surname><given-names>FL</given-names></name>, <name name-style="western"><surname>Chemin</surname><given-names>J</given-names></name>, et al</person-group>
<article-title>CACNA1H mutations are associated with different forms of primary aldosteronism</article-title>. <source/>EBioMedicine. <year>2016</year>;<volume>13</volume>:<fpage>225</fpage>–<lpage>236</lpage>.<pub-id pub-id-type="pmid">27729216</pub-id></mixed-citation>
</ref>
<ref id="CIT0015">
<label>[15]</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dubel</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Altier</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Chaumont</surname><given-names>S</given-names></name>, et al</person-group>
<article-title>Plasma membrane expression of T-type calcium channel alpha(1) subunits is modulated by high voltage-activated auxiliary subunits</article-title>. <source/>J Biol Chem. <year>2004</year>;<volume>279</volume>(<issue>28</issue>):<fpage>29263</fpage>–<lpage>29269</lpage>.<pub-id pub-id-type="pmid">15123697</pub-id></mixed-citation>
</ref>
<ref id="CIT0016">
<label>[16]</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Proft</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Rzhepetskyy</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Lazniewska</surname><given-names>J</given-names></name>, et al</person-group>
<article-title>The Cacna1h mutation in the GAERS model of absence epilepsy enhances T-type Ca<sup>2+</sup> currents by altering calnexin-dependent trafficking of Ca<sub>v</sub>3.2 channels</article-title>. <source/>Sci Rep. <year>2017</year>;<volume>7</volume>(<issue>1</issue>):<fpage>11513</fpage>.<pub-id pub-id-type="pmid">28912545</pub-id></mixed-citation>
</ref>
<ref id="CIT0017">
<label>[17]</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vitko</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Bidaud</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Arias</surname><given-names>JM</given-names></name>, et al</person-group>
<article-title>The I-II loop controls plasma membrane expression and gating of Ca(v)3.2 T-type Ca2+ channels: a paradigm for childhood absence epilepsy mutations</article-title>. <source/>J Neurosci. <year>2007</year>;<volume>27</volume>(<issue>2</issue>):<fpage>322</fpage>–<lpage>330</lpage>.<pub-id pub-id-type="pmid">17215393</pub-id></mixed-citation>
</ref>
<ref id="CIT0018">
<label>[18]</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arias-Olguín</surname><given-names>II</given-names></name>, <name name-style="western"><surname>Vitko</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Fortuna</surname><given-names>M</given-names></name>, et al</person-group>
<article-title>Characterization of the gating brake in the I-II loop of Ca(v)3.2 T-type Ca(2+) channels</article-title>. <source/>J Biol Chem. <year>2008</year>;<volume>283</volume>(<issue>13</issue>):<fpage>8136</fpage>–<lpage>8144</lpage>.<pub-id pub-id-type="pmid">18218623</pub-id></mixed-citation>
</ref>
<ref id="CIT0019">
<label>[19]</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khosravani</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Altier</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Simms</surname><given-names>B</given-names></name>, et al</person-group>
<article-title>Gating effects of mutations in the Cav3.2 T-type calcium channel associated with childhood absence epilepsy</article-title>. <source/>J Biol Chem. <year>2004</year>;<volume>279</volume>(<issue>11</issue>):<fpage>9681</fpage>–<lpage>9684</lpage>.<pub-id pub-id-type="pmid">14729682</pub-id></mixed-citation>
</ref>
<ref id="CIT0020">
<label>[20]</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khosravani</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Bladen</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Parker</surname><given-names>DB</given-names></name>, et al</person-group>
<article-title>Effects of Cav3.2 channel mutations linked to idiopathic generalized epilepsy</article-title>. <source/>Ann Neurol. <year>2005</year>;<volume>57</volume>(<issue>5</issue>):<fpage>745</fpage>–<lpage>749</lpage>.<pub-id pub-id-type="pmid">15852375</pub-id></mixed-citation>
</ref>
<ref id="CIT0021">
<label>[21]</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peloquin</surname><given-names>JB</given-names></name>, <name name-style="western"><surname>Khosravani</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Barr</surname><given-names>W</given-names></name>, et al</person-group>
<article-title>Functional analysis of Ca3.2 T-type calcium channel mutations linked to childhood absence epilepsy</article-title>. <source/>Epilepsia. <year>2006</year>;<volume>47</volume>(<issue>3</issue>):<fpage>655</fpage>–<lpage>658</lpage>.<pub-id pub-id-type="pmid">16529636</pub-id></mixed-citation>
</ref>
<ref id="CIT0022">
<label>[22]</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eckle</surname><given-names>VS</given-names></name>, <name name-style="western"><surname>Shcheglovitov</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Vitko</surname><given-names>I</given-names></name>, et al</person-group>
<article-title>Mechanisms by which a CACNA1H mutation in epilepsy patients increases seizure susceptibility</article-title>. <source/>J Physiol. <year>2014</year>;<volume>592</volume>(<issue>4</issue>):<fpage>795</fpage>–<lpage>809</lpage>.<pub-id pub-id-type="pmid">24277868</pub-id></mixed-citation>
</ref>
<ref id="CIT0023">
<label>[23]</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jurkovicova-Tarabova</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Cmarko</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Rehak</surname><given-names>R</given-names></name>, et al</person-group>
<article-title>Identification of a molecular gating determinant within the carboxy terminal region of Ca<sub>v</sub>3.3 T-type channels</article-title>. <source/>Mol Brain. <year>2019</year>;<fpage>34</fpage>.<pub-id pub-id-type="pmid">30961646</pub-id></mixed-citation>
</ref>
<ref id="CIT0024">
<label>[24]</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frazier</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Serrano</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>George</surname><given-names>EG</given-names></name>, et al</person-group>
<article-title>Gating kinetics of the alpha1I T-type calcium channel</article-title>. <source/>J Gen Physiol. <year>2001</year>;<volume>12</volume>(<issue>1</issue>):<fpage>457</fpage>–<lpage>470</lpage>.</mixed-citation>
</ref>
<ref id="CIT0025">
<label>[25]</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Serrano</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Perez-Reyes</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>SW</given-names></name></person-group>
<article-title>State-dependent inactivation of the alpha1G T-type calcium channel</article-title>. <source/>J Gen Physiol. <year>1999</year>;<volume>114</volume>(<issue>2</issue>):<fpage>185</fpage>–<lpage>201</lpage>.<pub-id pub-id-type="pmid">10435997</pub-id></mixed-citation>
</ref>
<ref id="CIT0026">
<label>[26]</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Berthier</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Monteil</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lory</surname><given-names>P</given-names></name>, et al</person-group>
<article-title>Alpha(1H) mRNA in single skeletal muscle fibres accounts for T-type calcium current transient expression during fetal development in mice</article-title>. <source/>J Physiol. <year>2002</year>;<volume>539</volume>(<issue>3</issue>):<fpage>681</fpage>–<lpage>691</lpage>.<pub-id pub-id-type="pmid">11897840</pub-id></mixed-citation>
</ref>
<ref id="CIT0027">
<label>[27]</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wakelam</surname><given-names>MJ</given-names></name></person-group>
<article-title>The fusion of myoblasts</article-title>. <source/>Biochem J. <year>1985</year>;<volume>228</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="pmid">3890835</pub-id></mixed-citation>
</ref>
<ref id="CIT0028">
<label>[28]</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Entwistle</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Zalin</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Bevan</surname><given-names>S</given-names></name>, et al</person-group>
<article-title>The control of chick myoblast fusion by ion channels operated by prostaglandins and acetylcholine</article-title>. <source/>J Cell Biol. <year>1988</year>;<volume>106</volume>(<issue>5</issue>):<fpage>1693</fpage>–<lpage>1702</lpage>.<pub-id pub-id-type="pmid">2453519</pub-id></mixed-citation>
</ref>
<ref id="CIT0029">
<label>[29]</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rapuano</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ross</surname><given-names>AF</given-names></name>, <name name-style="western"><surname>Prives</surname><given-names>J</given-names></name></person-group>
<article-title>Opposing effects of calcium entry and phorbol esters on fusion of chick muscle cells</article-title>. <source/>Dev Biol. <year>1989</year>;<volume>134</volume>(<issue>2</issue>):<fpage>271</fpage>–<lpage>278</lpage>.<pub-id pub-id-type="pmid">2472983</pub-id></mixed-citation>
</ref>
<ref id="CIT0030">
<label>[30]</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bijlenga</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Espinos</surname><given-names>E</given-names></name>, et al</person-group>
<article-title>T-type alpha 1H Ca2+ channels are involved in Ca2+ signaling during terminal differentiation (fusion) of human myoblasts</article-title>. <source/>Proc Natl Acad Sci U S A. <year>2000</year>;<volume>97</volume>(<issue>13</issue>):<fpage>7627</fpage>–<lpage>7632</lpage>.<pub-id pub-id-type="pmid">10861024</pub-id></mixed-citation>
</ref>
<ref id="CIT0031">
<label>[31]</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Canto-Bustos</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Loeza-Alcocer</surname><given-names>E</given-names></name>, <name name-style="western"><surname>González-Ramírez</surname><given-names>R</given-names></name>, et al</person-group>
<article-title>Functional expression of T-type Ca2+ channels in spinal motoneurons of the adult turtle</article-title>. <source/>PLoS One. <year>2014</year>;<volume>9</volume>(<issue>9</issue>):<fpage>e108187</fpage>.<pub-id pub-id-type="pmid">25255145</pub-id></mixed-citation>
</ref>
<ref id="CIT0032">
<label>[32]</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>David</surname><given-names>G</given-names></name></person-group>
<article-title>Stimulation-induced Ca(2+) influx at nodes of Ranvier in mouse peripheral motor axons</article-title>. <source/>J Physiol. <year>2016</year>;<volume>594</volume>(<issue>1</issue>):<fpage>39</fpage>–<lpage>57</lpage>.<pub-id pub-id-type="pmid">26365250</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>